This inventor holds 50 USPTO granted patents and 28 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Hormone Replacement Therapy (CPC class A61K). Top assignees: Therapeuticsmd, Inc., Sancilio & Company, Inc., Andrx Corporation, Inc.. Active years: 2004-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- St Petersburg, FL (US) (2020)
- Miami, FL (US) (2004 - 2023)
- St. Petersburg, FL (US) (2016 - 2024)
Company Filing History:
35 out of 59 
9 out of 11 
1 out of 8 
Years Active: 2004-2024
Areas of Expertise:
Title: Janice Louise Cacace: Pioneering Innovator in Hormonal Therapies
Introduction: Janice Louise Cacace, based in Miami, Florida, is a prominent inventor with an impressive portfolio of 50 patents. Her innovative work primarily focuses on developing advanced hormonal therapies, particularly in the realm of progesterone and estrogen formulations. Cacace's contributions are significant in enhancing patient care through improved pharmacokinetic profiles.
Latest Patents: Among her latest patents, Cacace's work on "Progesterone formulations having a desirable PK profile" stands out. This patent discloses various progesterone formulations and their applications, emphasizing methods that allow for reduced dosage while maintaining efficacy. Another notable patent is for "Natural combination hormone replacement formulations and therapies," which presents several formulations of estrogen and progesterone, including solubilized estradiol without progesterone and micronized progesterone with partially solubilized progesterone. These innovations aim to provide flexible and effective hormone replacement options for patients.
Career Highlights: Throughout her career, Janice Louise Cacace has worked with leading companies in the pharmaceutical industry, including TherapeuticsMD, Inc. and Sancilio & Company, Inc. Her work has significantly impacted hormone replacement therapy, showcasing her commitment to advancing medical solutions for a better patient experience.
Collaborations: Cacace has collaborated with notable professionals in her field, including Brian A. Bernick and Peter H. R. Persicaner. These partnerships have fostered innovation and have been instrumental in the development of her groundbreaking therapies.
Conclusion: Janice Louise Cacace's dedication to innovation in hormonal therapies places her among the notable inventors in the pharmaceutical sector. Her extensive patent portfolio reflects her commitment to improving patient care through effective and innovative formulations. As she continues to pioneer advancements in this critical field, her contributions undoubtedly lead to a brighter future for hormone-related health therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile